Spencer AP, Carson DS, Crouch MA.Vitamin E and coronary artery disease[J].Arch Intern Med, 1999, 159(12):1313-1320.
[2]
Kushi LH, Folsom AR, Prineas RJ, et al.Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women[J].N Engl J Med, 1996, 334(18):1156-1162.
Buring JE, Hennekens CH.Antioxidant vitamins and cardiovascular disease[J].Nutr Rev, 1997, 55:S53-58.
[6]
Christen WG, Gaziano JM, Hennekens CH.Design of Physicians'' Health Study II-a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials[J].Ann Epidemiol, 2000, 10(2):125-134.
[7]
Jadad AR, Moore RA, Carroll D, et al.Assessing the quality of reports of randomized clinical trials:Is blinding necessary?[J].Control Clin Trials, 1996, 17(1):1-12.
[8]
Group HPSC.MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20, 536 high-risk individuals:a randomised placebo-controlled trial[J].The Lancet, 2002, 360(9326):23-33.
[9]
Stephens NG, Parsons A, Schofield PM, et al.Randomised controlled trial of vitamin E in patients with coronary disease:Cambridge Heart Antioxidant Study(CHAOS)[J].Lancet, 1996, 347(9004):781-786.
[10]
Rapola JM, Virtamo J, Ripatti S, et al.Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction[J].The Lancet, 1997, 349(9067):1715-1720.
[11]
Gaetano GD, Collaborative Group of the Primary Prevention Project.Low-dose aspirin and vitamin E in people at cardiovascular risk:a randomised trial in general practice[J].Lancet, 2001, 357(9250):89-95.
[12]
Virtamo J, Rapola JM, Ripatti S, et al.Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease[J].Arch Intern Med, 1998, 158(6):668-675.
[13]
Boaz M, Smetana S, Weinstein T, et al.Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease(SPACE):randomised placebo-controlled trial[J].The Lancet, 2000, 356(9237):1213-1218.
[14]
Lonn E, Yusuf S, Hoogwerf B, et al.Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes:results of the HOPE study and MICRO-HOPE substudy[J].Diabetes Care, 2002, 25(11):1919-1927.
[15]
Sesso HD, Buring JE, Christen WG, et al.Vitamins E and C in the prevention of cardiovascular disease in men:the Physicians'' Health Study II randomized controlled trial[J].JAMA, 2008, 300(18):2123-2133.
[16]
Mann JF, Lonn EM, Yi Q, et al.Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency:results of the HOPE study[J].Kidney Int, 2004, 65(4):1375-1380.
[17]
Yusuf S, Dagenais G, Pogue J, et al.Vitamin E supplementation and cardiovascular events in high-risk patients.The Heart Outcomes Prevention Evaluation Study Investigators[J].N Engl J Med, 2000, 342(3):154-160.
[18]
Cook NR, Albert CM, Gaziano JM, et al.A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women:results from the Women''s Antioxidant Cardiovascular Study[J].Arch Intern Med, 2007, 167(15):1610-1618.
[19]
Lee IM, Cook NR, Gaziano JM, et al.Vitamin E in the primary prevention of cardiovascular disease and cancer-The Women''s Health Study:a randomized controlled trial[J].JAMA, 2005, 294(1):56-65.
[20]
Lonn E, Bosch J, Yusuf S, et al.Effects of long-term vitamin E supplementation on cardiovascular events and cancer:a randomized controlled trial[J].JAMA, 2005, 293(11):1338-1347.
[21]
Stampfer MJ, Hennekens CH, Manson JE, et al.Vitamin E consumption and the risk of coronary disease in women[J].N Engl J Med, 1993, 328:1444-1449.
